Staff and Content Validation Reviewer Disclosure:  The staff involved with this activity and any content validation reviewers of this activity have reported no relevant financial relationships with commercial interests.

Resolution of Conflicts of Interest: In accordance with the ACCME Standards for Commercial Support of CME, the Duke University School of Medicine implemented mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.

Faculty and Planning Committee/Faculty Disclosure:

Russell Hall, MD (Activity Medical Director)

Professor and Chair, Dermatology

Duke University

Durham, NC

Barbara Gilchrest, MD

Professor

Massachusetts General Hospital

Boston, MA

Arlene Ruiz de Luzuriaga, MD, MPH

Assistant Professor

University of Chicago

Chicago, IL

Jodi Johnson, PhD

Research Assistant Professor

Northwestern University

Evanston, IL

Katrina Abuabara, MD, MA

Department of Dermatology

University of Pennsylvania

Philadelphia, PA

David Margolis, MD

Department of Dermatology

University of Pennsylvania

Philadelphia, PA

The following speakers/aurthors and/or planning committee members have indicated they have no relationship(s) with industry to disclose relative to the content of this CME activity: 

• Arlene Ruiz de Luzuriaga, MD

• Jodi Lynn Johnson, PhD

The following speakers/authors and/or planning committee members have indicated that they have relationship(s) with industry to disclose:

• Russell Hall, MD, fulfills the role of consultant for GlaxoSmithKline and Syntimmune and fulfills the role on Data Safety Board for Genentech Roche and wrote manuscript for Society for UP to Date
• Barbara Gilchrest, MD, fulfills the role of Advisory Board Member for Chanel, Inc. and DUSA Pharmaceuticals; consultant for Chemderm, Inc.
• David Margolis, MD, fulfills the role of Advisory Board Member for Kerecis, Janssen, DermaSciences, Clementia and  GlaxoSmithKline

Acknowledgement of Commercial Support: This CME activity is supported by an educational grant from Lilly.

Unapproved Use Disclosure: Duke School of Medicine requires CME faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty at this symposium may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

Disclaimer: The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition.